UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056277
Receipt number R000064250
Scientific Title An evaluation trial of exercise performance following the intake of test food in corporate track and field athletes -Open trial-
Date of disclosure of the study information 2024/11/30
Last modified on 2024/11/26 15:50:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An evaluation trial of exercise performance following the intake of test food in corporate track and field athletes -Open trial-

Acronym

An evaluation trial of exercise performance following the intake of test food

Scientific Title

An evaluation trial of exercise performance following the intake of test food in corporate track and field athletes -Open trial-

Scientific Title:Acronym

An evaluation trial of exercise performance following the intake of test food

Region

Japan


Condition

Condition

Healthy Volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects on exercise performance after low-altitude and high-altitude training, and high-altitude adaptation following the continuous intake of test food.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ventilatory threshold related indicators

Key secondary outcomes

oxygen uptake, oxygen utilization efficiency, ventilation volume, carbon dioxide output, respiratory exchange ratio, respiratory rate, heart rate, exercise duration, subjective exercise intensity, urinary excretion volume of test food components


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

exercise load, test food

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) Individuals who consented to participate in this trial through a written agreement.
2) Healthy female.
3) Individuals who able to maintain a diet, drink, intake of test food, urination, and maintaining rest according to the schedule instructed by the test person in charge.

Key exclusion criteria

1) Individuals whose blood test results are judged to be ineligible for this trial by lead principal investigator.
2) Individuals with gastrointestinal, cardiovascular, endocrine, or other disorders, or with a history of such disorders, who are judged by lead principal investigator to be ineligible for the trial.
3) As a rule, individuals who regularly use drugs for the treatment of diseases.
4) Individuals who are taking healthy foods that may affect this trial.
5) Individuals with allergies.
6) Individuals judged to be ineligible for this trial due to other reasons by lead principal investigator.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Yasutaka
Middle name
Last name Ikeda

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Otsu Nutraceuticals Research Institute

Zip code

520-0106

Address

1-11-1 Karasaki, Otsu, Shiga

TEL

+81-77-519-0111

Email

Ikeda.Yasutaka@otsuka.jp


Public contact

Name of contact person

1st name Yasutaka
Middle name
Last name Ikeda

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Otsu Nutraceuticals Research Institute

Zip code

520-0106

Address

1-11-1 Karasaki, Otsu, Shiga

TEL

+81-77-519-0111

Homepage URL


Email

Ikeda.Yasutaka@otsuka.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Otsuka Pharmaceutical Co., Ltd.

Address

Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo 108-8242, Japan

Tel

+81-3-6717-1499

Email

shimizu_se@otsuka.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 30 Day


Related information

URL releasing protocol

Scheduled to be documented after publication.

Publication of results

Unpublished


Result

URL related to results and publications

Scheduled to be documented after publication.

Number of participants that the trial has enrolled

8

Results

Scheduled to be documented after publication.

Results date posted

2024 Year 11 Month 26 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Scheduled to be documented after publication.

Participant flow

Scheduled to be documented after publication.

Adverse events

Scheduled to be documented after publication.

Outcome measures

Scheduled to be documented after publication.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 17 Day

Date of IRB

2019 Year 06 Month 26 Day

Anticipated trial start date

2019 Year 06 Month 26 Day

Last follow-up date

2019 Year 11 Month 27 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 04 Month 08 Day


Other

Other related information



Management information

Registered date

2024 Year 11 Month 26 Day

Last modified on

2024 Year 11 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064250